EB618, First-in-Class Oral Tablet of Dual GLP-1/Glucagon Receptor Agonist for Patients with Obesity and Metabolic Disorders: Results from PK-PD Study in Non-Human Primates

Jun 13, 2026 from 2:15 PM to 3:45 PM EDT

Supporting Materials